ERn Financial LLC’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$160K Hold
29,574
0.03% 161
2026
Q1
$67.4K Hold
29,574
0.01% 149
2025
Q4
$118K Hold
29,574
0.02% 145
2025
Q3
$250K Hold
29,574
0.05% 126
2025
Q2
$333K Hold
29,574
0.07% 116
2025
Q1
$280K Hold
29,574
0.04% 159
2024
Q4
$333K Hold
29,574
0.05% 162
2024
Q3
$836K Sell
29,574
-30,000
-50% -$773K 0.13% 109
2024
Q2
$1.14M Hold
59,574
0.19% 81
2024
Q1
$1.95M Sell
59,574
-7,676
-11% -$245K 0.34% 61
2023
Q4
$2.01M Hold
67,250
0.38% 58
2023
Q3
$1.83M Buy
+67,250
New +$1.87M 0.4% 58

Other funds holding EVH

ERn Financial LLC's EVH Position: Q2 2026 in Review

ERn Financial LLC held its Evolent Health (EVH) position steady in Q2 2026 at 29,574 shares worth $160K. The position accounts for 0.03% of the portfolio, ranked #161.

ERn Financial LLC first reported a position in EVH in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.01M in Q4 2023. 36 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • ERn Financial LLC held 29,574 shares of Evolent Health worth $160K as of Q2 2026.
  • ERn Financial LLC left its Evolent Health share count unchanged in Q2 2026.
  • Evolent Health made up 0.03% of ERn Financial LLC's portfolio in Q2 2026, its #161 holding.
  • ERn Financial LLC first reported a position in Evolent Health in Q3 2023 and has held it in 12 quarters since.
  • ERn Financial LLC's Evolent Health position peaked at $2.01M in Q4 2023.
  • 36 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on ERn Financial LLC's 13F filing for Q2 2026, filed 23 Jul 2026.